Published in J Biol Chem on January 18, 2001
The glycosynapse. Proc Natl Acad Sci U S A (2002) 2.46
Specific tetraspanin functions. J Cell Biol (2001) 2.35
Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol (2006) 1.99
Targeting of tetraspanin proteins--potential benefits and strategies. Nat Rev Drug Discov (2008) 1.91
The CD81 partner EWI-2wint inhibits hepatitis C virus entry. PLoS One (2008) 1.86
Survival and proliferation factors of normal and malignant plasma cells. Int J Hematol (2003) 1.76
Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol Biol Cell (2002) 1.69
CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol (2008) 1.62
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J (2003) 1.50
Dynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Galpha q/11 association. Mol Biol Cell (2004) 1.36
GW body disassembly triggered by siRNAs independently of their silencing activity. Nucleic Acids Res (2007) 1.29
Single-molecule analysis of CD9 dynamics and partitioning reveals multiple modes of interaction in the tetraspanin web. J Cell Biol (2008) 1.29
Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J (2009) 1.28
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer (2006) 1.26
Tetraspanin CD81 is required for the alpha v beta5-integrin-dependent particle-binding step of RPE phagocytosis. J Cell Sci (2007) 1.24
Glycosylation defining cancer cell motility and invasiveness. Glycoconj J (2004) 1.24
Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily. Biophys J (2006) 1.18
A primate virus generates transformed human cells by fusion. J Cell Biol (2005) 1.17
Murine CD9 is the receptor for pregnancy-specific glycoprotein 17. J Exp Med (2002) 1.17
Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Mol Immunol (2007) 1.07
TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals. J Cell Biol (2012) 1.07
Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain. PLoS Pathog (2008) 1.05
Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. J Virol (2007) 1.01
Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains. J Virol (2007) 1.00
Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Am J Pathol (2008) 0.97
A transgenic insertion on mouse chromosome 17 inactivates a novel immunoglobulin superfamily gene potentially involved in sperm-egg fusion. Mamm Genome (2013) 0.95
Direct binding of the ligand PSG17 to CD9 requires a CD9 site essential for sperm-egg fusion. Mol Biol Cell (2003) 0.94
Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81. Nat Commun (2013) 0.93
Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport. Virol J (2013) 0.93
Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. J Biol Chem (2011) 0.92
Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo. Neoplasia (2009) 0.90
CD9 clustering and formation of microvilli zippers between contacting cells regulates virus-induced cell fusion. Traffic (2008) 0.90
The tetraspanin D6.1A and its molecular partners on rat carcinoma cells. Biochem J (2005) 0.88
The tetraspanins CD9 and CD81 regulate CD9P1-induced effects on cell migration. PLoS One (2010) 0.88
EWI-2/CD316 is an inducible receptor of HSPA8 on human dendritic cells. Mol Cell Biol (2007) 0.88
The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry. BMC Microbiol (2009) 0.87
Using regulatory and epistatic networks to extend the findings of a genome scan: identifying the gene drivers of pigmentation in merino sheep. PLoS One (2011) 0.86
The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways. J Biol Chem (2014) 0.85
Complex N-linked glycans serve as a determinant for exosome/microvesicle cargo recruitment. J Biol Chem (2014) 0.84
CD81 and hepatitis C virus (HCV) infection. Viruses (2014) 0.84
TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization. Cell Mol Life Sci (2015) 0.84
Increased density of retinal pigment epithelium in cd81-/- mice. J Cell Biochem (2004) 0.83
The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection. J Biol Chem (2009) 0.83
The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms. PLoS One (2013) 0.83
The developmental regulation of CD81 in the rat retina. Mol Vis (2007) 0.82
An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis. J Proteomics (2012) 0.82
The tetraspanin CD151 in papillomavirus infection. Viruses (2014) 0.81
Tetraspanins as therapeutic targets in hematological malignancy: a concise review. Front Physiol (2015) 0.81
The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci (2011) 0.81
Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells. Pflugers Arch (2007) 0.80
New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A. J Virol (2015) 0.80
CD9P-1 expression correlates with the metastatic status of lung cancer, and a truncated form of CD9P-1, GS-168AT2, inhibits in vivo tumour growth. Br J Cancer (2011) 0.80
Tetraspanins: Small transmembrane proteins with big impact on membrane microdomain structures. Commun Integr Biol (2008) 0.80
Cross-talk between tetraspanin CD9 and transmembrane adaptor protein non-T cell activation linker (NTAL) in mast cell activation and chemotaxis. J Biol Chem (2013) 0.79
Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol (2015) 0.79
Metastasis-associated cell surface oncoproteomics. Front Pharmacol (2012) 0.79
Distinct regions of the large extracellular domain of tetraspanin CD9 are involved in the control of human multinucleated giant cell formation. PLoS One (2014) 0.78
Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL. Biochem J (2011) 0.77
IgSF8: a developmentally and functionally regulated cell adhesion molecule in olfactory sensory neuron axons and synapses. Mol Cell Neurosci (2012) 0.76
Evolution and Structural Analyses of Glossina morsitans (Diptera; Glossinidae) Tetraspanins. Insects (2014) 0.76
A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth. Br J Cancer (2011) 0.75
CD151: Basis Sequence: Mouse. AFCS Nat Mol Pages (2015) 0.75
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet (2005) 4.17
Tetraspanins. Cell Mol Life Sci (2001) 3.33
Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res (2001) 2.90
Severely reduced female fertility in CD9-deficient mice. Science (2000) 2.80
Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella. J Infect Dis (1975) 2.66
Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) (1975) 2.61
Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol (2003) 2.36
Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA (1983) 2.29
Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res (2001) 2.28
West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis (2001) 2.15
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol (1996) 2.10
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A (2001) 1.85
Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol (2001) 1.84
Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum (2001) 1.84
Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery (1995) 1.80
Insensitivity of peptidoglycan biosynthetic reactions to beta-lactam antibiotics in a clinical isolate of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 1.78
Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Genet (2000) 1.73
Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J (1999) 1.72
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial. Leukemia (2007) 1.63
Disc space infection and vertebral osteomyelitis as a complication of percutaneous lateral discectomy. Clin Orthop Relat Res (1987) 1.62
Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob Chemother (2004) 1.60
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother (1988) 1.55
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother (2003) 1.55
Prevalence of HIV antibodies in transsexual and female prostitutes. Am J Public Health (1992) 1.47
Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum (1992) 1.42
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987). Cytogenet Cell Genet (1987) 1.40
Human live anthrax vaccine in the former USSR. Vaccine (1994) 1.40
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. Infection (2007) 1.39
Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem (1991) 1.38
Absence of mesangial IgA in AIDS: a postmortem study. Nephron (1991) 1.38
Evaluation of canines for accelerant detection at fire scenes. J Forensic Sci (1994) 1.38
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest (1992) 1.35
IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol (1982) 1.34
Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis (2008) 1.31
Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer (1990) 1.31
Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest (1983) 1.29
CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J Biol Chem (1998) 1.26
CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. Eur J Immunol (2000) 1.25
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res (2001) 1.24
Tetraspanins and malignancy. Expert Rev Mol Med (2001) 1.23
Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer (1999) 1.22
CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J Immunol (1994) 1.20
Scanning electron microscopic study of microcrystals implicated in human rheumatic diseases. Scan Electron Microsc (1980) 1.20
Sequence and expression of seven new tetraspans. Biochim Biophys Acta (2000) 1.19
DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet (2001) 1.19
Two-dimensional electrophoresis of plasma polypeptides reveals "high" heterozygosity indices. Proc Natl Acad Sci U S A (1983) 1.18
Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res (2000) 1.17
Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med (1975) 1.16
Tissue penetration of amphotericin B in Candida endocarditis. Chest (1974) 1.16
Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother (1994) 1.14
The untold story of HUT78. Science (1990) 1.14
Immunohistologic localization of "facteur thymique serique" (FTS) in human thymic epithelium. J Immunol (1981) 1.14
Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. N Engl J Med (1974) 1.13
Solubilization of an antigen associated with certain bronchial tumours. Eur J Cancer (1975) 1.12
Molecular cloning of a novel human leukemia-associated gene. Evidence of conservation in animal species. J Biol Chem (1989) 1.12
Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol (1997) 1.12
CD9, but not other tetraspans, associates with the beta1 integrin precursor. Eur J Immunol (1997) 1.12
Hereditary diffuse articular chondrocalcinosis. Dominant manifestation without close linkage with the HLA system in a large pedigree. Scand J Rheumatol (1977) 1.09
Formalin treatment of radiation-induced hemorrhagic proctitis. Am J Gastroenterol (1986) 1.09
Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. J Biol Chem (1991) 1.09
Cell surface hydrophobicity of pigmented and nonpigmented clinical Serratia marcescens strains. Infect Immun (1986) 1.08
Graves' disease: in situ localization of lymphoid T cell subpopulations. Clin Exp Immunol (1983) 1.07
Regional analysis of functions and demographics of health information managers. J AHIMA (1996) 1.06
CD9 and megakaryocyte differentiation. Blood (2001) 1.06
Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene (1999) 1.06
Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol (1990) 1.05
Nm23-H1 mutation in neuroblastoma. Nature (1994) 1.05
Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias. Oncogene (1996) 1.04
Adherence properties of Staphylococcus aureus under static and flow conditions: roles of agr and sar loci, platelets, and plasma ligands. Infect Immun (2001) 1.04
The in-vitro anti-rickettsial activity of macrolides. J Antimicrob Chemother (1996) 1.03
Corynebacterium diphtheriae endocarditis. Am J Med Sci (1976) 1.03
In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. J Antimicrob Chemother (2003) 1.02
Involvement of OP18 in cell proliferation. Biochem Biophys Res Commun (1991) 1.02
Identification of genetic variants in erythrocyte lysate by two-dimensional gel electrophoresis. Am J Hum Genet (1984) 1.01
Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest (1998) 1.01
Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel. Eur J Clin Microbiol Infect Dis (2006) 1.00
Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann N Y Acad Sci (2001) 1.00